SCHEMBL4299821

SCHEMBL4299821

C=CCN1CCCN(C(=O)CCCCCCCCCCCCC)CC1C

nearest known ligand 0.50

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.50
MEN1 O00255 2/20 0.49
KMT2A Q03164 2/20 0.49
POLB P06746 1/20 0.49
MAPT P10636 1/20 0.49
TDP1 Q9NUW8 1/20 0.49
GNAI3 P08754 9/20 0.43
GNAI1 P63096 9/20 0.43
GNAO1 P09471 8/20 0.43
ATM Q13315 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4300859 0.92 GNAI3 (0.47) L3MBTL1MEN1KMT2APOLBMAPT
SCHEMBL4301850 0.79 MEN1 (0.60) L3MBTL1MEN1KMT2APOLBMAPT
SCHEMBL4308322 0.77 GNAI3 (0.53) L3MBTL1MEN1KMT2APOLBMAPT
SCHEMBL4306408 0.77 GNAI3 (0.53) L3MBTL1MEN1KMT2APOLBMAPT
SCHEMBL4308311 0.77 GNAI3 (0.53) L3MBTL1MEN1KMT2APOLBMAPT
SCHEMBL4304325 0.77 GNAI3 (0.53) L3MBTL1MEN1KMT2APOLBMAPT
SCHEMBL4301981 0.76 HPGD (0.48) L3MBTL1MEN1KMT2APOLBMAPT
SCHEMBL4301970 0.76 HPGD (0.48) L3MBTL1MEN1KMT2APOLBMAPT
SCHEMBL9762648 0.74 L3MBTL1 (0.88) L3MBTL1MEN1KMT2APOLBMAPT
SCHEMBL13290614 0.73 L3MBTL1 (0.85) L3MBTL1MEN1KMT2APOLBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2054398-A1 NEW HETEROCYCLIC COMPOUNDS CONTAINING NITROGEN ATOMS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME FOR TREATMENT OF CANCER Korea Research Institute of Bioscience and Biotechnology (KR) 2009-05-06 EP disclosed
WO-2008018778-A1 NEW HETEROCYCLIC COMPOUNDS CONTAINING NITROGEN ATOMS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME FOR TREATMENT OF CANCER KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) 2008-02-14 WO disclosed